Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.

Endocrine - 1 Jan 2021

Poli Roberta, Scatolini Maria, Grosso Enrico, Maletta Francesca, Gallo Marco, Liscia Daniele, Nelva Anna, Cesario Flora, Forte Giuseppe, Metovic Jasna, Volante Marco, Arvat Emanuela, Papotti Mauro

Abstract excerpt

PURPOSE: Struma ovarii (SO) is a highly specialized ovarian teratoma, consisting of thyroid tissue. Rarely, carcinomas histologically identical to their thyroid counterparts may occur, and are comprehensively defined as malignant struma ovarii (MSO). Their optimal management is controversial, and the molecular profile of the malignant counterpart in the ovary is incompletely known. In this study, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to GTP Phosphohydrolases
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 3

Share to Membrane Proteins

Share to Mutation

Share to Ovarian Neoplasms

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 32743766
DOI: 10.1007/s12020-020-02438-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.PMID 32743766Read ↗

Malignant struma ovarii: Advances in molecular pathogenesis, classification, diagnosis and treatment.Semantic proximity Read ↗

Malignant struma ovarii: clinicopathological and molecular features in a series of nine cases.Semantic proximity Read ↗

Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.Semantic proximity Read ↗

The molecular profile of ovarian struma ovarii.Semantic proximity Read ↗

Malignant Clinical Course of Histologically Benign Ovarian Struma: case report and literature reviewSemantic proximity Read ↗

Clinical Analysis of Struma OvarySemantic proximity Read ↗

Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.Semantic proximity Read ↗

RET/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: A case report and review of the literatureSemantic proximity Read ↗

Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.Semantic proximity Read ↗

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?Semantic proximity Read ↗

Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.Semantic proximity Read ↗

RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.